An International Survey of Allogeneic Hematopoietic Cell Transplantation for X-Linked Agammaglobulinemia

ConclusionBased on the concept in which IgRT is the standard treatment for XLA, HCT may be an effective and safe alternative treatment option for XLA patients, and IgRT can be discontinued following transplantation. It is ideal to perform HCT in XLA patients for whom transplantation is indicated before they develop organ damage.
Source: Journal of Clinical Immunology - Category: Allergy & Immunology Source Type: research